Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026

Hims & Hers will report Q2 2026 financial results after market close on Monday, Aug. 10, 2026, followed by a live conference call at 5:00 p.m. ET. The announcement is procedural with no new financial or guidance figures, so near-term impact is likely limited.

Analysis

This is effectively non-news from a fundamental perspective; the market should not assign much signal value to an earnings-date notice by itself. The only immediate mechanism is event-volatility anchoring: if HIMS options are already pricing a large move, that premium can persist or bleed as the date approaches, but the company has not disclosed anything that changes revenue, margin, or guidance expectations.

For HIMS, the real tradeable variable is not the calendar date but whether the next print changes the market’s view on subscriber retention, cohort economics, and regulatory durability of its direct-to-consumer model. Into the event window, the stock can still drift on positioning and short interest, but any move driven by this announcement alone is likely to fade unless paired with a material change in implied move or analyst revisions. The first falsifier is simple: if option-implied volatility does not stay elevated relative to realized, there is no edge in expressing a view here.

Consensus may be over-fixated on headline growth and underweight the risk that margins compress if customer acquisition costs re-accelerate. The more interesting medium-term question is whether HIMS can sustain growth without leaning on promotional intensity; if not, multiple expansion should stall even if topline remains strong. For now, this is a watch item, not a thesis event.

Key Decisions for Investors

• No outright equity position on the earnings-date notice alone; wait for the print or pre-earnings revisions before expressing a view on HIMS.
• If HIMS 30- to 45-day implied volatility is materially above its 1-year realized volatility into the event, consider a defined-risk short-vol structure only with tight size limits; exit if implied move widens further on analyst chatter.
• Set an alert for any pre-earnings estimate revisions to gross margin or customer acquisition costs; those are the variables that would justify a directional trade in HIMS over the next 1-3 months.
• If HIMS rallies into the event without corresponding upward revisions, consider a short into earnings against a smaller basket of profitable internet/healthcare growth names; the risk/reward improves only if the market is paying for perfection.